The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Urologix Inc. (NSDQ:ULGX) is heralding the results of a long-term study on its enlarged prostate treatment device.
Data from a study published in The Journal of Urology show that the Minneapolis-based medical device manufacturer’s Cooled ThermoTherapy (CTT) is safe and effective at treating both symptoms and obstruction associated with benign prostatic hyperplasia (BPH), the company reported.
Many business professionals likely dream of the day when they’ll run a company as chief executive, but how many hope to lead two start-ups simultaneously?
Juventas hopes to begin enrolling patients in a trial of its regenerative medicine technology beginning in the second quarter, and complete enrollment by the end of the year, CEO Rahul Aras said.
Critical limb ischemia is a severe obstruction of the arteries that decreases blood flow to the extremities and can result in amputation.
By Mary Vanac
Clinical-stage regenerative medicine company Juventas Therapeutics Inc. — a Cleveland Clinic spin-out initially named AcelleRX Therapeutics Inc. — started enrolling patients in a Phase 1 clinical trial to evaluate the safety and efficacy of its leading stem cell factor for treating heart failure.
